See every side of every news story
Published loading...Updated

Comparison of antimicrobial resistance in Pseudomonas aeruginosa from intensive care and non-intensive care units and its impact on treatment decisions - AMR Insights

Summary by AMR Insights
This study compares antimicrobial resistance of P. aeruginosa from ICU and non-ICU patients, revealing that 30% were from ICU patients and 70% from non-ICU patients. Resistance to ciprofloxacin and piperacillin-tazobactam was higher in ICU patients than non-ICU patients. The prevalence of DTR P. aeruginosa was similar between the two groups, but joint resistance to imipenem and ceftazidime was more prevalent in ICU patients. Carbapenemase-produc…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

AMR Insights broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.